Biogen/ US09062X1037 /
| 1/7/2025 9:59:58 PM | Chg. -0.14 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 153.12USD | -0.09% | 44,876 Turnover: 6.91 mill. |
-Bid Size: - | -Ask Size: - | 22.32 bill.USD | - | 19.10 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 8.02 USD | -61.74% |
| EPS Diluted: | 7.97 USD | -61.81% |
| Revenues per Share: | 67.66 USD | -3.90% |
| Book Value per Share: | 101.81 USD | 9.87% |
| Cash Flow per Share: | 10.64 USD | 11.09% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 9,835.60 USD | -3.32% |
| Net Income: | 1,161.10 USD | -61.89% |
| Operating Cash Flow: | 1,547.20 USD | - |
| Cash and Cash Equivalents: | 1,049.90 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 19.10 | 32.27 |
| P/S Ratio: | 2.26 | 3.82 |
| P/BV ratio: | 1.50 | 2.54 |
| P/CF Ratio: | 14.39 | 24.31 |
| PEG: | -0.31 | -0.52 |
| Earnings Yield: | 5.24% | 3.10% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 22.32 bill. USD | 37.62 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 145.72 mill. | |
Profitability
| Gross Profit Margin: | 74.24% |
| EBIT Margin: | 0.00% |
| Net Profit Margin: | 11.81% |
| Return on Equity: | 7.85% |
| Return on Assets: | 4.33% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.31% |
| Liquidity II / Quick Ratio: | 0.79% |
| Liquidity III / Current Ratio: | 2.00% |
| Debt / Equity Ratio: | 0.47% |
| Dynam. Debt / Equity Ratio: | 778.53% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 12/31/2023 |
| Accounting Standard: | US GAAP |
| Currency: | USD |